Rhenman & Partners Asset Management Ab Becton Dickinson & CO Transaction History

Rhenman & Partners Asset Management Ab

$959 Million
Q4 2024

A detailed history of Rhenman & Partners Asset Management Ab transactions in Becton Dickinson & CO stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 47,900 shares of BDX stock, worth $10.7 Million. This represents 1.13% of its overall portfolio holdings.

Number of Shares

47,900

Previous 112,500 57.42%

Holding current value

$10.7 Million

Previous $27.1 Million 59.93%

% of portfolio

1.13%

Previous 2.26%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$220.02 - $243.75 $14.2 Million - $15.7 Million	-64,600 Reduced 57.42%	47,900 $10.9 Million
Q3 2024 Nov 13, 2024	SELL	$221.47 - $242.41 $110,735 - $121,205	-500 Reduced 0.44%	112,500 $27.1 Million
Q2 2024 Aug 13, 2024	SELL	$225.07 - $246.17 $675,210 - $738,510	-3,000 Reduced 2.59%	113,000 $26.4 Million
Q1 2024 May 14, 2024	BUY	$233.45 - $247.73 $27.1 Million - $28.7 Million	116,000 New	116,000 $28.7 Million
Q2 2023 Aug 11, 2023	SELL	$238.39 - $265.32 $1.67 Million - $1.86 Million	-7,000 Reduced 6.86%	95,000 $25.1 Million
Q1 2023 May 11, 2023	BUY	$229.71 - $259.35 $4.36 Million - $4.93 Million	19,000 Added 22.89%	102,000 $25.2 Million
Q4 2022 Feb 13, 2023	SELL	$218.29 - $256.91 $436,580 - $513,820	-2,000 Reduced 2.35%	83,000 $21.1 Million
Q3 2022 Nov 14, 2022	BUY	$51.03 - $264.23 $2.04 Million - $10.6 Million	40,000 Added 88.89%	85,000 $20.1 Million
Q2 2022 Aug 12, 2022	BUY	$234.74 - $275.42 $117,370 - $137,710	500 Added 1.12%	45,000 $11.1 Million
Q1 2022 May 13, 2022	SELL	$243.64 - $270.48 $11.3 Million - $12.6 Million	-46,500 Reduced 51.1%	44,500 $11.8 Million
Q4 2021 Feb 11, 2022	BUY	$230.08 - $250.94 $7.59 Million - $8.28 Million	33,000 Added 56.9%	91,000 $23 Million
Q3 2021 Nov 12, 2021	BUY	$232.72 - $256.47 $2.33 Million - $2.56 Million	10,000 Added 20.83%	58,000 $14.3 Million
Q2 2021 Aug 13, 2021	SELL	$232.65 - $254.58 $8.61 Million - $9.42 Million	-37,000 Reduced 43.53%	48,000 $11.7 Million
Q1 2021 May 14, 2021	BUY	$232.09 - $256.88 $9.28 Million - $10.3 Million	40,000 Added 88.89%	85,000 $20.7 Million
Q4 2020 Jan 19, 2021	BUY	$221.92 - $245.94 $2.22 Million - $2.46 Million	10,000 Added 28.57%	45,000 $11.3 Million
Q3 2020 Oct 13, 2020	BUY	$215.77 - $276.76 $3.02 Million - $3.87 Million	14,000 Added 66.67%	35,000 $8.14 Million
Q2 2020 Jul 16, 2020	BUY	$219.9 - $263.41 $1.54 Million - $1.84 Million	7,000 Added 50.0%	21,000 $5.03 Million
Q1 2020 Apr 16, 2020	SELL	$195.69 - $279.01 $3.91 Million - $5.58 Million	-20,000 Reduced 58.82%	14,000 $3.22 Million
Q4 2019 Jan 17, 2020	SELL	$236.45 - $266.82 $6.86 Million - $7.74 Million	-29,000 Reduced 46.03%	34,000 $9.25 Million
Q3 2019 Oct 16, 2019	SELL	$230.58 - $256.08 $3.92 Million - $4.35 Million	-17,000 Reduced 21.25%	63,000 $15.9 Million
Q2 2019 Jul 22, 2019	BUY	$217.4 - $246.08 $1.09 Million - $1.23 Million	5,000 Added 6.67%	80,000 $20.2 Million
Q1 2019 Apr 11, 2019	SELL	$206.05 - $248.17 $8.24 Million - $9.93 Million	-40,000 Reduced 34.78%	75,000 $18.7 Million
Q4 2018 Feb 05, 2019	BUY	$204.73 - $257.93 $7.17 Million - $9.03 Million	35,000 Added 43.75%	115,000 $25.9 Million
Q3 2018 Oct 03, 2018	SELL	$233.07 - $256.0 $1.17 Million - $1.28 Million	-5,000 Reduced 5.88%	80,000 $20.9 Million
Q2 2018 Jul 20, 2018	BUY	$208.1 - $233.85 $2.08 Million - $2.34 Million	10,000 Added 13.33%	85,000 $20.4 Million
Q1 2018 Apr 11, 2018	BUY	$205.46 - $240.27 $15.4 Million - $18 Million	75,000 New	75,000 $16.3 Million

Others Institutions Holding BDX

# of Institutions

1,803

Shares Held

260M

Call Options Held

1.27M

Put Options Held

1.09M

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.9B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.

Account

Rhenman & Partners Asset Management Ab Becton Dickinson & CO Transaction History